Adimmune Corp Sustainability Reports

Adimmune Corporation is a biotechnology company that develops, manufactures, and supplies human vaccines, including influenza and cell-cultured products. It also provides contract development and manufacturing organization (CDMO) services for international pharmaceutical partners.

Sector: Manufacturing

Country: Taiwan

Exchange: Taiwan Stock Exchange

LEI: 549300M5TV8YGVXU1827

FIGI: BBG001SJNXX1

13 reports from 2020 to 2025

• Adimmune Corp 2025 Sustainability Report
• Adimmune Corp 2024 Consolidated Financial Statements and Independent Auditors’ Report
• Adimmune Corp 2024 Sustainability Report
• Adimmune Corp 2023 Sustainability Report
• Adimmune Corp 2023 Parent Company Only Financial Statements and Independent Auditors' Report